Xylo Technologies Ltd (XYLO)
NASDAQ: XYLO · Real-Time Price · USD
3.145
+0.155 (5.18%)
Nov 20, 2024, 4:00 PM EST - Market closed

Company Description

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally.

The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments.

It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease.

The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities.

In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform.

Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles.

The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024.

Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

Xylo Technologies Ltd
Xylo Technologies logo
Country Israel
Founded 1999
Industry Medical Devices
Sector Healthcare
Employees 84
CEO Liron Carmel

Contact Details

Address:
10 Hanechoshet, 4th Floor
Tel Aviv, 6971072
Israel
Website medigus.com

Stock Details

Ticker Symbol XYLO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001618500
ISIN Number US58471G4091
SIC Code 7374

Key Executives

Name Position
Liron Carmel Chief Executive Officer
Tali Dinar Chief Financial Officer
Ilan Oren Executive Officer

Latest SEC Filings

Date Type Title
Nov 15, 2024 424B5 Filing
Nov 15, 2024 6-K Report of foreign issuer
Oct 31, 2024 6-K Report of foreign issuer
Sep 25, 2024 6-K Report of foreign issuer
Sep 20, 2024 6-K Report of foreign issuer
Aug 15, 2024 6-K Report of foreign issuer
Aug 14, 2024 6-K Report of foreign issuer
Jul 30, 2024 6-K Report of foreign issuer
Jul 22, 2024 424B3 Prospectus
Jun 7, 2024 144 Filing